Allianz Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $306K | Sell |
|
|||||
|
2021
Q3 | $337K | Buy |
|
|||||
|
2021
Q2 | $243K | Hold |
|
|||||
|
2021
Q1 | $237K | Sell |
|
|||||
|
2020
Q4 | $298K | Sell |
|
|||||
|
2020
Q3 | $290K | Sell |
|
|||||
|
2020
Q2 | $347K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2.14M | Sell |
|
|||||
|
2018
Q1 | $7.06M | Buy |
|
|||||
|
2017
Q4 | $7.14M | Buy |
|
|||||
|
2017
Q3 | $7.53M | Sell |
|
|||||
|
2017
Q2 | $11.7M | Sell |
|
|||||
|
2017
Q1 | $13.6M | Buy |
|
|||||
|
2016
Q4 | $8.1M | Sell |
|
|||||
|
2016
Q3 | $7.59M | Sell |
|
|||||
|
2016
Q2 | $5.48M | Sell |
|
|||||
|
2016
Q1 | $10.8M | Sell |
|
|||||
|
2015
Q4 | $26.1M | Sell |
|
|||||
|
2015
Q3 | $26.4M | Buy |
|
|||||
|
2015
Q2 | $26.6M | Buy |
|
|||||
|
2015
Q1 | $12.3M | Buy |
|
|||||
|
2014
Q4 | $2.24M | Sell |
|
|||||
|
2014
Q3 | $1.85M | Buy |
|
|||||
|
2014
Q2 | $1.76M | Sell |
|
|||||
|
2014
Q1 | $1.61M | Buy |
|